Monitor the integration of the acquired AME platform and its commercial performance over the next 12 months, as this will determine the actual cost of the acquisition. The technology could diversify Inspira's revenue streams beyond medical devices into advanced manufacturing. Watch for updates on the strategic direction of both the medical and new technology divisions.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 6 $0.1000entry
- T+1 · 7mo ago 0.00%α −0.06% · $0.1000
- T+5 · 7mo ago −40.00%α −44.13% · $0.0600
- T+20 · 7mo ago −32.00%α −40.98% · $0.0680
- T+60 · 5mo ago −82.00%α −95.47% · $0.0180
Price Chart
How similar events traded
Executive Summary
Inspira Technologies acquired Nano Dimension's AME and Fabrica businesses for up to $12.5 million, consisting of a $2 million upfront payment and up to $10.5 million in deferred payments tied to future performance. The acquisition includes intellectual property, manufacturing equipment, inventory, and customer contracts, expanding Inspira's technological capabilities beyond its core medical device business.
Key Facts
- Inspira Technologies acquired Nano Dimension's AME and Fabrica businesses
- Total consideration is up to $12.5 million: $2 million upfront payment and up to $10.5 million in deferred payments
- Deferred payments are tied to future performance over 12 months: 50% of AME net cash proceeds (capped at $4M) and 50% of Fabrica net cash proceeds (capped at $6.5M)
- Acquisition includes intellectual property, proprietary 3D electronic printing systems, engineering know-how, manufacturing equipment, inventory, and customer-related assets
- Transaction closed on April 6, 2026
- Inspira's existing medical business operations will continue independently in a wholly owned subsidiary
Financial Impact
Up to $12.5 million total consideration with $2 million immediate cash outflow and performance-based deferred payments
Risk Factors
- Deferred consideration could reach maximum of $10.5 million if performance targets are exceeded
- Integration challenges of new technology platform with existing medical business
- Dilution risk if Inspira needs to raise additional capital to fund operations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001185185-26-001275 |
| Document: iinn6k040626.htm | 0001185185-26-001275 |
| Document: iinnex99-1.htm | 0001185185-26-001275 |
| Document: 0001185185-26-001275-index-headers.html | 0001185185-26-001275 |
| Document: 0001185185-26-001275-index.html | 0001185185-26-001275 |
| Document: 0001185185-26-001275.txt | 0001185185-26-001275 |
Track record
11 reports on IINNW
2 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +213.25% at T+5 after the May 18, 2026 report. 2 of 4 went positive at some point.
Filters
- May 19, 202625w ago 6-K Neutral 4/10 Entry $0.1420 to $0.1200 ▼ −15.49% −16.48% vs SPY
- May 18, 202626w ago 6-K Bullish 6/10 Entry $0.0830 to $0.1310 ▲ +57.83% +56.25% vs SPY
- Apr 16, 202630w ago 6-K Bullish 7/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
- Apr 16, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
- Apr 15, 202630w ago 6-K Neutral 3/10 Entry $0.1100 to $0.0690 ▼ −37.27% −43.09% vs SPY
- Apr 14, 202630w ago 6-K Neutral 3/10 Entry $0.0720 to $0.0690 ▼ −4.17% −10.46% vs SPY
- Apr 13, 202631w ago 6-K Bullish 7/10 Entry $0.0600 to $0.0690 ▲ +15.00% +7.27% vs SPY
- Apr 6, 202632w ago 6-K Bullish 8/10 Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
- Apr 6, 202632w ago 6-K Bullish 7/10 Viewing Entry $0.1000 to $0.0680 ▼ −32.00% −40.98% vs SPY
- Mar 31, 202632w ago 6-K Neutral 4/10 Entry $0.0800 to $0.0690 ▼ −13.75% −23.17% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers